The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning

Cancer Immunity

Volumn 4, Issue , 2004, Pages

  Vaughan, Hilary A ^a   St Clair, Fiona ^a   Scanlan, Matthew J ^b   Chen, Yao Tsen ^c   Maraskovsky, Eugene ^a   Sizeland, Andrew ^d   Old, Lloyd J ^b   Cebon, Jonathan ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Head and neck cancer; Human; mRNA; SEREX; Tissue distribution; Tumor antigens

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; IMMUNOGLOBULIN G ANTIBODY; TUMOR ANTIGEN; ZINC FINGER PROTEIN;

ANTIBODY TITER; ARTICLE; BRAIN; BRAIN TISSUE; CANCER CELL CULTURE; CANCER PATIENT; GENE EXPRESSION; GENE ISOLATION; HEAD AND NECK CANCER; HUMORAL IMMUNITY; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; THYMUS;

EID: 13444291430     PISSN: 14249634     EISSN: 14249634     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6-29. (PMID: 9449931)
2. Resser JR, Carbone DP. Immunotherapy of head and neck cancer. Curr Opin Oncol 1998; 10: 226-32. (PMID: 9619359)
3. Whiteside TL. Immunobiology and immunotherapy of head and neck cancer. Curr Oncol Rep 2001; 3: 46-55. (PMID: 11123869)
4. Van den Eynde B, Hainaut P, Herin M, Knuth A, Lemoine C, Weynants P, van der Bruggen P, Fauchet R, Boon T. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989; 44: 634-40. (PMID: 2529220)
5. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognised by T lymphocytes. Annu Rev Immunol 1994; 12: 337-65. (PMID: 8011285)
6. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 1997; 94: 1914-8. (PMID: 9050879)
7. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, Brasseur R, Chomex P, De Backer O, Cavanee W, Boon T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360-9. (PMID: 7927540)
8. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32. (PMID: 12445278)
9. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W. Immunity to oncogenic proteins. Immunol Rev 1995; 145: 33-59. (PMID: 7590829)
10. Disis ML, Cheever MA. Oncogenic proteins as tumor antigens. Curr Opin Immunol 1996; 8: 637-42. (PMID: 8902388)
11. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, Old LJ. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A 1998; 95: 6919-23. (PMID: 9618514)
12. Tureci O, Chen YT, Sahin U, Gure AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M. Expression of SSX genes in human tumors. Int J Cancer 1998; 77: 19-23. (PMID: 9639388)
13. Mandruzzato S, Brasseur F, Andry G, Boon T, van der Bruggen P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J Exp Med 1997; 186: 785-93. (PMID: 9271594)
14. Stoss O, Schwaiger FW, Cooper TA, Stamm S. Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J Biol Chem 1999; 274: 10951-62. (PMID: 10196175)
15. Kikuchi M, Nakao M, Inoue Y, Matsunaga K, Shichijo S, Yamana H, Itoh K. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes. Int J Cancer 1999; 81: 459-66. (PMID: 10209962)
16. Shichijo S, Nakao M, Imai Y, Takasu H, Kawamoto M, Niiya F, Yang D, Toh Y, Yamana H, Itoh K. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J Exp Med 1998; 187: 277-88. (PMID: 9449708)
17. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A 1995; 92: 11810-3. (PMID: 8524854)
18. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998; 187: 1163-7. (PMID: 9547328)
19. Jager E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jager D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc Natl Acad Sci U S A 2000; 97: 4760-5. (PMID: 10781081)
20. Jager E, Jager D, Karbach J, Chen YT, Ritter G, Nagata Y, Gnjatic S, Stockert E, Arand M, Old LJ, Knuth A. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000; 191: 625-30. (PMID: 10684854)
21. Jager E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jager D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998; 187: 265-70. (PMID: 9432985)
22. Jager E, Jager D, Knuth A. CTL-defined cancer vaccines: perspectives for active immunotherapeutic interventions in minimal residual disease. Cancer Metastasis Rev 1999; 18: 143-50. (PMID: 10505552)
23. Romero P, Dutoit V, Rubio-Godoy V, Lienard D, Speiser D, Guillaume P, Servis K, Rimoldi D, Cerottini JC, Valmori D. CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences. Clin Cancer Res 2001; 7(3 Suppl): 766s-72s. (PMID: 11300471)
24. Valmori D, Dutoit V, Lienard D, Rimoldi D, Pittet MJ, Champagne P, Ellefsen K, Sahin U, Speiser D, Lejeune F, Cerottini JC, Romero P. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res 2000; 60: 4499-506. (PMID: 10969798)
25. Zarour HM, Storkus WJ, Brusic V, Williams E, Kirkwood JM. NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells. Cancer Res 2000; 60: 4946-52. (PMID: 10987311)
26. Davis ID. An overview of cancer immunotherapy. Immunol Cell Biol 2000; 78: 179-95. (PMID: 10849106)
27. Jager E, Jager D, Knuth A. Clinical cancer vaccine trials. Curr Opin Immunol 2002; 14: 178-82. (PMID: 11869889)
28. Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, Kuwano M, Kohno K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 1998; 273: 5997-6000. (PMID: 9497311)
29. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dorken B, Royer HD. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 1997; 3: 447-50. (PMID: 9095180)
30. Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M, Nakano H. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 1999; 85: 2450-4. (PMID: 10357417)
31. Bossone SA, Asselin C, Patel AJ, Marcu KB. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci U S A 1992; 89: 7452-6. (PMID: 1502157)
32. Izzo MW, Strachan GD, Stubbs MC, Hall DJ. Transcriptional repression from the c-myc P2 promoter by the zinc finger protein ZF87/MAZ. J Biol Chem 1999; 274: 19498-506. (PMID: 10383467)
33. Li S, Ku CY, Farmer AA, Cong YS, Chen CF, Lee WH. Identification of a novel cytoplasmic protein that binds specifically to nuclear localization signal motifs. J Biol Chem 1998; 273: 6183-9. (PMID: 9497340)
34. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-8. (PMID: 9610721)
35. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jager D, Jager E, Knuth A, Chen YT, Old LJ. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999; 83: 456-64. (PMID: 10508479)
36. SEREX database. URL: http://www.licr.org/SEREX.html
37. Koseki T, Inohara N, Chen S, Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sc U S A 1998; 95: 5156-60. (PMID: 9560245)
38. Yamada E, Tsujikawa K, Itoh S, Kameda Y, Kohama Y, Yamamoto H. Molecular cloning and characterization of a novel human STE20-like kinase, hSLK. Biochim Biophys Acta 2000; 1495: 250-62. (PMID: 10699464)
39. Sabourin LA, Tamai K, Seale P, Wagner J, Rudnicki MA. Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region. Mol Cell Biol 2000; 20: 684-96. (PMID: 10611247)
40. Schwartz Y, Ben-Dor I, Navon A, Motro B, Nir U. Tyrosine phosphorylation of the TATA element modulatory factor by the FER nuclear tyrosine kinases. FEBS Lett 1998; 434: 339-45. (PMID: 9742951)
41. Sun CT, Lo WY, Wang IH, Lo YH, Shiou SR, Lai CK, Ting LP. Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON. J Biol Chem 2001; 276: 24059-67. (PMID: 11306577)
42. Jiang W, Jimenez G, Wells NJ, Hope TJ, Wahl GM, Hunter T, Fukunaga R. PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 1998; 2: 877-85. (PMID: 9885575)
43. Bergsagel PL, Timblin CR, Eckhardt L, Laskov R, Kuehl WM. Sequence and expression of a murine cDNA encoding PC326, a novel gene expressed in plasmacytomas but not normal plasma cells. Oncogene 1992; 7: 2059-64. (PMID: 1408147)
44. Kikuno R, Nagase T, Suyama M, Waki M, Hirosawa M, Ohara O. HUGE: a database for human large proteins identified in the Kazusa cDNA sequencing project. Nucleic Acids Res 2000; 28: 331-2. (PMID: 10592264)
45. Brass N, Racz A, Bauer C, Heckel D, Sybrecht G, Meese E. Role of amplified genes in the production of autoantibodies. Blood 1999; 93: 2158-66. (PMID: 10090922)
46. Disis ML, Cheever MA. HER-2/neu oncogenic protein: issues in vaccine development. Crit Rev Immunol 1998; 18: 37-45. (PMID: 9419446)
47. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci U S A 1998; 95: 7608-13. (PMID: 9636197)
48. Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 1997; 272: 6416-22. (PMID: 9045665)
49. Gure AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 1998; 58: 1034-41. (PMID: 9500467)
50. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht G, Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 1997; 6: 33-9. (PMID: 9002667)
51. Scanlan MJ, Gout I, Gordan CM, Williamson B, Gure AO, Jager D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: definition and quantitative analysis of mRNA expression. Cancer Immun 2001; 1: 4. (PMID: 12747765)
52. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9. (PMID: 2440339)
53. Kruse N, Pette M, Toyka K, Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J Immunol Methods 1997; 210: 195-203. (PMID: 9520302)